Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA.
School of Science and Engineering, Tulane University, New Orleans, LA, USA.
J Perinatol. 2023 Mar;43(3):259-270. doi: 10.1038/s41372-022-01466-7. Epub 2022 Jul 29.
Prenatal opioid exposure has recently risen four-fold with limited data on the developmental effects on neonatal physiology. The objective of this systematic review is to develop an association between prenatal opioid exposure and fetal and neonatal cardiac and autonomic development and function. The review was conducted in accordance with PRISMA Guidelines, and searches were conducted using PubMed, Embase, CINAHL, and Web of Science between May 25 and October 27, 2020. Twenty studies fit inclusion criteria, in four categories: (1) fetal cardiac outcomes, (2) neonatal cardiac outcomes, (3) noninvasive autonomic outcomes, and (4) clinical and behavioral measures. For the meta-analysis, three studies (total of 210 subjects) were included. Effect sizes were measured as the mean difference in fetal heart rate between opioid-exposed and non-exposed groups. Mothers with prenatal opioid use had a significantly lower fetal heart rate as compared to mothers without prenatal opioid use, requiring further studies to determine clinical significance.
产前阿片类药物暴露最近增加了四倍,但关于其对新生儿生理发育影响的数据有限。本系统评价的目的是建立产前阿片类药物暴露与胎儿和新生儿心脏及自主神经发育和功能之间的关联。该评价符合 PRISMA 指南,于 2020 年 5 月 25 日至 10 月 27 日期间在 PubMed、Embase、CINAHL 和 Web of Science 上进行了检索。有 20 项研究符合纳入标准,分为四类:(1)胎儿心脏结局,(2)新生儿心脏结局,(3)非侵入性自主神经结局,以及(4)临床和行为措施。对于荟萃分析,纳入了三项研究(共 210 名受试者)。效应量的测量方法是暴露于阿片类药物的胎儿心率与未暴露于阿片类药物的胎儿心率之间的平均差异。与未使用产前阿片类药物的母亲相比,使用产前阿片类药物的母亲的胎儿心率明显较低,需要进一步研究以确定其临床意义。